HAND2-AS1 can inhibit migration, invasion, and stemness by reducing TGF-β1 expression, as well as phosphorylated Smad2 and Smad3 levels, in NSCLC [119]. The gene discussed is SMAD2; the disease is non-small cell lung carcinoma.